These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12902886

  • 1. Triplet chemotherapy combination with gemcitabine, cisplatin and ifosfamide in patients with advanced non-small-cell lung cancer: phase II study.
    Mohedano Mohedano N, Sánchez Rovira P, Lozano Barriuso A, Fernandez Morales M, Medina Magan B, Jaen Morago A, Porras Quintela I, Dueñas Garcia R, Fernandez Flores E, Moreno Moreno MA.
    Am J Clin Oncol; 2003 Aug; 26(4):363-5. PubMed ID: 12902886
    [Abstract] [Full Text] [Related]

  • 2. Phase I study with dose escalation of gemcitabine and cisplatin in combination with ifosfamide (GIP) in patients with non-small-cell lung carcinoma.
    Bourgeois H, Billiart I, Chabrun V, Chieze S, Lemerre D, Germain T, Ferrand V, Meurice JC, Daban A, Tourani JM.
    Am J Clin Oncol; 2004 Feb; 27(1):89-95. PubMed ID: 14758140
    [Abstract] [Full Text] [Related]

  • 3. Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Chen YM, Perng RP, Whang-Peng J, Wu HW, Lin WC, Tsai CM.
    Lung Cancer; 2000 Dec; 30(3):199-202. PubMed ID: 11137205
    [Abstract] [Full Text] [Related]

  • 4. Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer: results of a phase II study.
    Planchard D, Bourgeois H, Adoun M, Paitel JF, Blanc P, Genet D, Ferru A, Meurice JC, Deletage C, Tourani JM.
    Am J Clin Oncol; 2006 Aug; 29(4):345-51. PubMed ID: 16891860
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.
    Alberola V, Camps C, Provencio M, Isla D, Rosell R, Vadell C, Bover I, Ruiz-Casado A, Azagra P, Jiménez U, González-Larriba JL, Diz P, Cardenal F, Artal A, Carrato A, Morales S, Sanchez JJ, de las Peñas R, Felip E, López-Vivanco G, Spanish Lung Cancer Group.
    J Clin Oncol; 2003 Sep 01; 21(17):3207-13. PubMed ID: 12947054
    [Abstract] [Full Text] [Related]

  • 6. Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: a phase II study of the italian oncology group for clinical research (GOIRC).
    Boni C, Bisagni G, Savoldi L, Moretti G, Rondini E, Sassi M, Zadro A, De Pas T, Franciosi V, Pazzola A, Vignoli R, Banzi MC, Pajetta V.
    Int J Cancer; 2000 Sep 01; 87(5):724-7. PubMed ID: 10925367
    [Abstract] [Full Text] [Related]

  • 7. Weekly gemcitabine and monthly cisplatin for advanced non-small cell lung carcinoma.
    Abratt RP, Hacking DJ, Goedhals L, Bezwoda WR.
    Semin Oncol; 1997 Jun 01; 24(3 Suppl 8):S8-18-S8-23. PubMed ID: 9207311
    [Abstract] [Full Text] [Related]

  • 8. Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens.
    Kosmas C, Tsavaris N, Panopoulos C, Vadiaka M, Stavroyianni N, Kourelis T, Malamos N, Antonopoulos M, Kalofonos HP.
    Eur J Cancer; 2001 May 01; 37(8):972-8. PubMed ID: 11334721
    [Abstract] [Full Text] [Related]

  • 9. A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer.
    Vadell-Nadal C, Nogué-Aliguer M, Fabregat-Mayol X, Saigí-Grau E, Gallén-Castillo M.
    Lung Cancer; 2000 May 01; 28(2):109-15. PubMed ID: 10717328
    [Abstract] [Full Text] [Related]

  • 10. Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC).
    Antón A, Díaz-Fernández N, González Larriba JL, Vadell C, Masutti B, Montalar J, Barneto I, Artal A, Rosell R.
    Lung Cancer; 1998 Nov 01; 22(2):139-48. PubMed ID: 10022221
    [Abstract] [Full Text] [Related]

  • 11. Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.
    Perng RP, Chen YM, Ming-Liu J, Tsai CM, Lin WC, Yang KY, Whang-Peng J.
    J Clin Oncol; 1997 May 01; 15(5):2097-102. PubMed ID: 9164223
    [Abstract] [Full Text] [Related]

  • 12. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
    Gebbia V, Galetta D, Caruso M, Verderame F, Pezzella G, Valdesi M, Borsellino N, Pandolfo G, Durini E, Rinaldi M, Loizzi M, Gebbia N, Valenza R, Tirrito ML, Varvara F, Colucci G, Gruppo Ocologico Italia Meridionale.
    Lung Cancer; 2003 Feb 01; 39(2):179-89. PubMed ID: 12581571
    [Abstract] [Full Text] [Related]

  • 13. An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
    Pectasides D, Kalofonos HP, Samantas E, Nicolaides C, Papacostas P, Onyenadum A, Visvikis A, Skarlos D, Fountzilas G.
    Anticancer Res; 2001 Feb 01; 21(4B):3005-10. PubMed ID: 11712802
    [Abstract] [Full Text] [Related]

  • 14. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK, Kocha W, Gagliardi A, Eady A, Newman TE.
    Cancer Prev Control; 1999 Feb 01; 3(1):84-94. PubMed ID: 10474757
    [Abstract] [Full Text] [Related]

  • 15. A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.
    Kosmas C, Tsavaris NB, Makatsoris T, Onyenadum A, Vadiaka M, Stavroyianni N, Sepsas E, Dimitropoulos D, Rokana S, Kalofonos HP.
    Int J Cancer; 2002 Mar 01; 98(1):141-7. PubMed ID: 11857398
    [Abstract] [Full Text] [Related]

  • 16. Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma.
    Shin SJ, Kim H, Baek JH, Ahn JJ, Jegal Y, Seo KW, Park CR, Shin JK, Jung JP, Kim JW, Cha HJ, Kwon WJ, Jeong AK, Noh YJ, Park JH, Min YJ.
    Lung Cancer; 2008 Apr 01; 60(1):83-91. PubMed ID: 18006180
    [Abstract] [Full Text] [Related]

  • 17. Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study.
    Piantedosi FV, Caputo F, Mazzarella G, Gilli M, Pontillo A, D'Agostino D, Campbell S, Marsico SA, Bianco A.
    Cancer Chemother Pharmacol; 2008 Apr 01; 61(5):803-7. PubMed ID: 17639396
    [Abstract] [Full Text] [Related]

  • 18. Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC).
    Baldini E, Ardizzoni A, Prochilo T, Cafferata MA, Boni L, Tibaldi C, Neumaier C, Conte PF, Rosso R, Italian Lung Cancer Task Force.
    Br J Cancer; 2001 Nov 16; 85(10):1452-5. PubMed ID: 11720427
    [Abstract] [Full Text] [Related]

  • 19. A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer.
    Sculier JP, Lafitte JJ, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Paesmans M, Berghmans T, European Lung Cancer Working Party.
    Ann Oncol; 2007 Jun 16; 18(6):1037-42. PubMed ID: 17404152
    [Abstract] [Full Text] [Related]

  • 20. Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.
    Rudd RM, Gower NH, Spiro SG, Eisen TG, Harper PG, Littler JA, Hatton M, Johnson PW, Martin WM, Rankin EM, James LE, Gregory WM, Qian W, Lee SM.
    J Clin Oncol; 2005 Jan 01; 23(1):142-53. PubMed ID: 15625369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.